The proposed transaction values VERAXA Biotech AG at USD 1.64 billion with expected gross cash proceeds up to USD 253 million held in trust by Voyager Acquisition Corp.

The resurrection of the dire wolf by Colossal Biosciences marks a fascinating intersection of popular culture and ...

Ten dystopian novels that hit a little too close to home for Gen Z, tackling climate dread, tech overreach, and the trauma of ...

Union minister Jitendra Singh and Jammu and Kashmir Chief Minister Omar Abdullah on Saturday jointly inaugurated the ...

In a significant push for urban infrastructure, Union Minister Dr. Jitendra Singh today inaugurated the first-ever ...

Provident Data Centers, a division of leading Dallas-based real estate and investment firm Provident, announces the appointment of Jack Backes as Principal Strategist. An accomplished professional ...

Aerovate Therapeutics, Inc. ("Aerovate") today announced that its stockholders have approved the proposed merger (the "Merger") with Jade Biosciences, Inc. ("Jade"), along with all proposals related ...

reverse engineering, production machining, metrology, and inspection and manufacturing workflows. In addition, it offers software platforms, including 3D Sprint and 3DXpert, which are metal and ...

Genome editing has advanced at a rapid pace with promising results for treating genetic conditions—but there is always room ...

"Manufacturing these cutting-edge products inherently requires a workforce with enhanced knowledge and skills." ...